Adiposity predicts cognitive decline in older persons with diabetes: A 2-year follow-up

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Abbatecola, Angela Marie ^a   Lattanzio, Fabrizia ^a   Spazzafumo, Liana ^b   Molinari, Anna Maria ^c   Cioffi, Michele ^c   Canonico, Raffaele ^c   DiCioccio, Luigi ^d   Paolisso, Giuseppe ^c  

^a INRCA   (Italy)

^b Scientific Direction   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Santa Scolastica Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INTERLEUKIN 6; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; BODY FAT; BODY MASS; COGNITIVE DEFECT; CONTROLLED STUDY; DIET THERAPY; FOLLOW UP; GLUCOSE TOLERANCE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; METABOLIC REGULATION; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; RISK ASSESSMENT; SCORING SYSTEM; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BODY FAT DISTRIBUTION; PREDICTIVE VALUE; RISK FACTOR;

ADIPOSITY; AGED; AGED, 80 AND OVER; BODY FAT DISTRIBUTION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 77956417885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010333     Document Type: Article

References (30)

1. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavourably affected in elderly diabetic subjects: results of the epidemiology of vascular aging study. Diabetes Care 24: 366-370.
2. Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48: 2460-2469.
3. Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, et al. (2009) Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 32: 221-226.
4. Abbatecola AM, Rizzo MR, Barbieri M, Grella R, Arciello A, et al. (2006) Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics. Neurology 67: 235-240.
5. Yan SD, Chen X, Fu J, Chen M, Zhu H, et al. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's diesease. Nature 382: 685-691.
6. Geroldi C, Frisoni GB, Paolisso G, Bandinelli S, Lamponi M, et al. (2005) Insulin resistance in cognitive impairment: the In CHIANTI study. Arch Neurol 62: 1067-1072.
7. Lyon CJ, Law RE, Hsueh WA (2003) Minireview: Adiposity, Inflammation, and Atherogenesis. Endocrinology; 144: 2195-2200.
8. Han C, Jo SA, Seo JA, Kim BG, Kim NH, et al. (2009) Adiposity parameters and cognitive function in the elderly: Application of ''Jolly Fat'' hypothesis to cognition. Arch Gerontol Geriatr 49(2): e133-e138.
9. Dore GA, Elias MF, Robbins MA, Budge MM, Elias PK (2008) Relation between central adiposity and cognitive function in the Maine-Syracuse Study: attenuation by physical activity. Ann Behav Med 35: 341-350.
10. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R (2007) Measures of adiposity and dementia risk in elderly persons. Arch Neurol 64: 392-398.
11. Beydoun MA, Lhotsky A, Wang Y, Dal Forno G, An Y, et al. (2008) Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease. Am J Epidemiol 168: 1179-1189.
12. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB (2003) Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord 27: 260-268.
13. Wolf PA, Beiser A, Elias MF, Au R, Vasan RS, et al. (2007) Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res (4): 111-116.
14. Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, et al. (2006) Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 29: 345-351.
15. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, et al. (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62: 1556-1560.
16. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr., Yaffe K (2005) Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 330: 1360-1362.
17. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R (2007) Measures of adiposity and dementia risk in elderly persons. Arch Neurol 64: 392-398.
18. Gallagher D, Ruts E, Visser M, Heshka S, Baumgartner RN, et al. (2000) Weight stability masks sarcopenia in elderly men and women. Am J Physiol Endocrinol Metab 279: E366-E375.
19. Sam S, Haffner S, Davidson MH, D'Agostino RB, Sr, Feinstein S, et al. (2009) Relation of Abdominal Fat Depots to Systemic Markers of Inflammation in Type 2 Diabetes. Diabetes Care 32: 932-937.
20. Trujillo ME, Scherer PE (2005) Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257: 167-175.
21. Holden KF, Lindquist K, Tylavsky FA, Rosano C, Harris TB, et al. (2009) Serum leptin level and cognition in the elderly: Findings from the Health ABC Study. Serum leptin levels are associated with cognitive function in older adults. Neurobiol Aging 30(9): 1483-1489.
22. Chen B, Liao WQ, Xu N, Xu H, Wen JY, et al. (2009) Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res 1273: 129-137.
23. Thomson R, Brinkworth GD, Buckley JD, Noakes M, Clifton PM (2007) Good agreement between bioelectrical impedance and dual-energy X-ray absorpti-ometry for estimating changes in body composition during weight loss in overweight young women. Clin Nutr 26: 771-777.
24. Ritchie JD, Miller CK, Smiciklas-Wright H (2005) Tanita foot-to-foot bioelectrical impedance analysis system validated in older adults. J Am Diet Assoc 105: 1617-1619.
25. Lezak M, Howieson D, Loring D (2004) Neuropsychological Assessment. Fourth edition. Oxford, UK.
26. Lamberty GJ, Putnam SH, Chatel DM (1994) Derived Trail Making Test indices. Neuropsychol Behav Neurol 7: 230-234.
27. Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1: 385-401.
28. Friedewald WT, Levy R, Fredricson DS (1972) Estimation of serum low density lipoprotein without the use of a preparative ultracentrifuge. Clin Chem 18: 499-502.
29. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, et al. (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutrition 6: 407-413.
30. Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, et al. (1997) Longterm instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation 96: 1750-1754.